Moderna launches mRNA bird flu vaccine trial
Digest more
Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...
Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat. CAMBRIDGE, MA / ACC ...
Dr. Elias Sayour says the mRNA vaccine is helping shed new light on cancer treatments. “There have been patients that have ...
The FDA has assigned mRNA-1010 a PDUFA target date of 5 August 2026. If approved, mRNA-1010 will be the first seasonal ...
New findings reveal mRNA vaccines engage different dendritic cell subtypes to activate anti-tumor immunity, providing ...
Indian American physician-scientist Dr. Vinod Balachandran says mRNA vaccines may reduce risk of disease coming back after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results